Your browser doesn't support javascript.
loading
Preferential Inhibition of Wnt/ß-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade, Abhishek; Pathak, Vibha; Augelli-Szafran, Corinne E; Wei, Han-Xun; Oliver, Patsy; Suto, Mark; Buchsbaum, Donald J.
Afiliación
  • Gangrade A; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. abhigan8@gmail.com.
  • Pathak V; Department of Chemistry, Drug Discovery Division, Southern Research, Birmingham, AL 35205, USA. vpathak@southernresearch.org.
  • Augelli-Szafran CE; Department of Chemistry, Drug Discovery Division, Southern Research, Birmingham, AL 35205, USA. caugelli-szafran@southernresearch.org.
  • Wei HX; Department of Chemistry, Drug Discovery Division, Southern Research, Birmingham, AL 35205, USA. hweihml@hotmail.com.
  • Oliver P; Division of Pulmonary, Allergy and Critical Care, University of Alabama at Birmingham, Birmingham, AL 35233, USA. poliver@uab.edu.
  • Suto M; Department of Chemistry, Drug Discovery Division, Southern Research, Birmingham, AL 35205, USA. msuto@southernresearch.org.
  • Buchsbaum DJ; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. djb@uab.edu.
Int J Mol Sci ; 19(5)2018 May 20.
Article en En | MEDLINE | ID: mdl-29783777

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bencimidazoles / Vía de Señalización Wnt / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Bencimidazoles / Vía de Señalización Wnt / Neoplasias de la Mama Triple Negativas / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos